|
Vaneeva A.S., Ivshina A.V., Filimonova O.G.
Assessment of risk factors for osteoporosis in patients with osteoarthritis
|
№2 / 2024
|
|
A.A. Kondrashov, N.A. Shostak
Bone mineral density and androgenic status in men with rheumatoid arthritis
|
№12 / 2021
|
|
E.A. Kulyaev (1), A.V. Grafov (1), O. V. Falameeva (1), V.S. Kholodkin (1), M.A Sadovoy (1, 2), O.V. Tsygankova (2)
EXPERIENCE OF THE USE OF ZOLEDRONIC ACID (REZOLLASTIN 5 MG/6.25 ML, OOO «NATIVA») IN PATIENTS WITH LOW BONE MINERAL DENSITY IN THE SETTINGS OF THE CENTER FOR PREVENTION OF OSTEOPOROSIS OF NOVOSIBIRSK SRITO
|
№19 / 2017
|
|
P.S. Kovalenko, I.S. Dydykina, A.V. Smirnov, S.I. Glukhova, L.I. Alekseeva, E.L. Nasonov
THE EXPERIENCE OF THE USE OF DENOSUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS WITH OSTEOPOROSIS
|
№7 / 2017
|
|
M.E. Telnova, N.A. Petunina
BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
|
№5 / 2017
|
|
E.V. Biryukova
MODERN OPPORTUNITIES OF BONE ANABOLIC THERAPY OF OSTEOPOROSIS
|
№5 / 2017
|
|
A.V. Pashentseva, A.F. Verbovoy
OSTEOPOROSIS IN MEN
|
№16 / 2016
|
|
S.S. Rodionova, U.R. Khakimov
RATIONALE FOR USE OF ALFACALCIDOL IN COMBINATION WITH BISPHOSPHONATES IN POSTMENOPAUSAL AND SENILE FORMS OF SYSTEMIC OSTEOPOROSIS
|
№s3-16 / 2016
|
|
D.V. Stafeev, A.Yu. Kochish, S.N. Ivanov
EVALUATION OF THE EFFICACY OF THERAPY OF OSTEOPOROSIS IN PATIENTS WITH EXTRA-ARTICULAR FRACTURES OF THE PROXIMAL FEMUR
|
№5 / 2016
|
|
I.E. Zhila, O.V. Galkina, E.O. Bogdanova, N.L. Shaporova, O.V. Dudina
OSTEOPOROSIS IN PATIENTS WITH BRONCHO-OBSTRUCTIVE PATHOLOGY
|
№s4-15 / 2015
|
|
T.L. Karonova (1, 2), AT Andreeva (1), EV Mokhova (1), M.V. Budanova (1), E.N. Grineva (1, 2)
THE ROLE OF VITAMIN D DEFICIENCY IN THE FORMATION OF OSTEOPENIC SYNDROME IN YOUNG OBESE WOMEN AND WOMEN WITH NORMAL BODY WEIGHT
|
№s4-15 / 2015
|
|
N.V. Toroptsova, O.A. Nikitinskaja, T.A. Korotkova, N.V. Demin, S.G. Anikin
TREATMENT OF OSTEOPOROSIS: ISSUES OF DENOSUMAB EFFECTIVENESS AND SAFETY IN CLINICAL PRACTICE
|
№16 / 2015
|
Русский
